Intraoperative identification of esophageal sentinel lymph nodes with near-infrared fluorescence imaging  by Parungo, Cherie P. et al.
Evolving Technology Parungo et al
ETIntraoperative identification of esophageal sentinel lymph
nodes with near-infrared fluorescence imaging
Cherie P. Parungo, MDa
Shunsuke Ohnishi, MD, PhDc
Sang-Wook Kim, PhDd
Sunjee Kim, PhDd
Rita G. Laurence, BSa
Edward G. Soltesz, MDa
Frederick Y. Chen, MD, PhDa
Yolonda L. Colson, MD, PhDb
Lawrence H. Cohn, MDa
Moungi G. Bawendi, PhDdJohn V. Frangioni, MD, PhDcFrom the Cardiac Surgery Research Labo-
ratorya and Department of Thoracic Sur-
gery,b Brigham & Women’s Hospital, and
the Division of Hematology/Oncology and
Department of Radiology, Beth Israel Dea-
coness Medical Center,c Boston, Mass, and
the Department of Chemistry, Massachusetts
Institute of Technology,d Cambridge, Mass.
Supported by National Institutes of Health
grant NRSA F32 HL72568-01 (C.P.P), the
US Department of Energy (Office of Bio-
logical and Environmental Research) grant
DE-FG02-01ER63188 (J.V.F.), a Proof of
Principle Award from the Center for Inte-
gration of Medicine and Innovative Tech-
nology (J.V.F), and National Institutes of
Health grant R21/R33 EB-00673 (J.V.F.
and M.G.B.).
Received for publication May 29, 2004;
revisions received July 29, 2004; accepted
for publication Aug 2, 2004.
Address for reprints: John V. Frangioni, MD,
PhD, Department of Hematology/Oncology
and Department of Radiology, Beth Israel
Deaconess Medical Center, 330 Brookline
Ave, Room SL-B05, Boston, MA, 02215 (E-
mail: jfrangio@bidmc.harvard.edu)
J Thorac Cardiovasc Surg 2005;129:844-50
0022-5223/$30.00
Copyright © 2005 by The American Asso-
ciation for Thoracic Surgery
Parungo, Colson, Cohn, Laurence, Frangioni,
Ohnishi (left to right)doi:10.1016/j.jtcvs.2004.08.001
844 The Journal of Thoracic and CardioObjective: In esophageal cancer, selective removal of involved lymph nodes could
improve survival and limit complications from extended lymphadenectomy. Map-
ping with vital blue dyes or technetium Tc-99m often fails to identify intrathoracic
sentinel lymph nodes. Our purpose was to develop an intraoperative method for
identifying sentinel lymph nodes of the esophagus with high-sensitivity near-
infrared fluorescence imaging.
Methods: Six Yorkshire pigs underwent thoracotomy and received submucosal,
esophageal injection of quantum dots, a novel near-infrared fluorescent lymph tracer
designed for retention in sentinel lymph nodes. Six additional pigs underwent
thoracotomy and received submucosal esophageal injection of CW800 conjugated
to human serum albumin, another novel lymph tracer designed for uptake into
distant lymph nodes. Finally, 6 pigs received submucosal injection of the fluoro-
phore-conjugated albumin with an endoscopic needle through an esophagascope.
These lymph tracers fluoresce in the near-infrared, permitting visualization of
migration to sentinel lymph nodes with a custom intraoperative imaging system.
Results: Injection of the near-infrared fluorescent lymph tracers into the esophagus
revealed communicating lymph nodes within 5 minutes of injection. In all 6 pigs
that received quantum dot injection, only a single sentinel lymph node was identi-
fied. Among pigs that received fluorophore-conjugated albumin injection, in 5 of
12 a single sentinel lymph node was revealed, but in 7 of 12 two sentinel lymph
nodes were identified. There was no dominant pattern in the appearance of the
sentinel lymph nodes either cranial or caudal to the injection site.
Conclusion: Near-infrared fluorescence imaging of sentinel lymph nodes is a novel
and reliable intraoperative technique with the power to assist with identification and
resection of esophageal sentinel lymph nodes.
In esophageal cancer, extensive lymphadenectomy may improve survival1;however, it also increases morbidity and mortality.2 Selective removal ofinvolved lymph nodes could minimize the extent of lymphadenectomy yetstill provide accurate staging and local control. Unfortunately, currentmethods of identifying involved lymph nodes, including computed tomog-raphy, positron emission tomography, and endoscopic ultrasonography, are
only 60% to 80% accurate.3 Similarly, sentinel lymph node (SLN) mapping with
vital blue dyes or radioactive tracers is neither sufficient nor adequate in the setting
of esophageal cancer. In the thorax, intraoperative mapping with blue dye identifies
the SLNs in fewer than 50% of cases because of poor tissue penetration and
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gamma probes miss more than 50% of radioactive nodes
from the esophagus.5 The purpose of this study was to test
the ability of two novel near-infrared (NIR) fluorescent
lymph tracers to identify SLNs of the esophagus. Our hope
was that these findings could provide the basis for advanc-
ing further studies of NIR fluorescence technology for clin-
ical applications, namely providing selective removal of
esophageal lymph nodes for accurate staging information
without the need for extensive lymphadenectomy.
Material and Methods
Preparation of Lymph Tracers
NIR quantum dots (QDs) designed for retention in the first drain-
ing lymph node have been previously described elsewhere.6
Briefly, these type II core/shell QDs are semiconductor nanocrys-
tals that contain an inorganic core of cadmium telluride, an inor-
ganic shell of cadmium selenide, and an outer organic coating of
solubilizing oligomeric phosphines. Hydrodynamic diameter mea-
sured by gel filtration is 15 to 20 nm. These particular QDs were
engineered to fluoresce in the NIR, with peak emission at 840 nm.
A stock solution of 0.2-mol/L QDs in phosphate-buffered saline
solution, pH 7.4, was used for all studies.
HSA800, designed with a hydrodynamic diameter of 7 nm for
migration to distant lymph nodes, will be described in detail
elsewhere (Ohnishi et al, unpublished data). Briefly, human serum
albumin (HSA) was covalently conjugated to the NIR fluorophore
CW800 by means of an amide bond (HSA800). The ratio of
CW800 to albumin was 3.4:1. Peak absorbance and emission of
HSA800 were 778 nm and 795 nm, respectively, in phosphate
buffered saline solution, pH 7.4. A stock solution of 0.8-mg/mL
HSA800 in phosphate-buffered saline solution was used for all
studies. These fluorescent biologic labels are excellent tracers for
SLN mapping because they are highly fluorescent, nonradioactive,
and easily visible deep within tissue.
Direct Injection of QDs into the Submucosa of the
Esophagus
All protocols were in compliance with the “Guide for the Care and
Use of Laboratory Animals” (http://www.nap.edu/catalog/
5140.html). Adult, male Yorkshire pigs (mean weight 35 kg) were
anesthetized intramuscularly with tiletamine and zolazepam (Tela-
zol, 4.4 mg/kg) and xylazine (2.2 mg/kg) and subsequently with
isoflurane (0.5%-5% to effect). The animals were intubated, pre-
pared, and draped in the usual fashion. Pigs underwent a left
cervical, right thoracotomy, or left subcostal incision to visualize
the upper, middle, or lower esophagus, respectively (n  2 for
each group). Submucosal injection of 100 L of 0.2-mol/L NIR
QDs in phosphate-buffered saline solution, pH 7.4, into either the
upper, middle, or lower esophagus was performed. Injections of
the lymph tracer were performed by the same surgeon with iden-
tical technique.
Direct or Endoscopic Injection of HSA800
Six pigs underwent the same procedure except with direct injection
of HSA800 (dye concentration 10 mol/L) into the submucosa of
the upper, middle, or lower esophagus (n  2 for each segment).
The Journal of ThoraciAn additional 6 pigs underwent submucosal injection of 100 L
HSA800 with a rigid esophagascope and an endoscopic injecting
needle. Injections of the lymph tracer were performed by the same
surgeon with identical technique.
Identification and Resection of the SLNs
The NIR-fluorescence imaging system has been described else-
where in detail.7 Briefly, it is composed of a 400- to 700-nm
“white” light (0.5 mW/cm2) and a 725- to 775-nm NIR fluores-
cence excitation light (5 mW/cm2). Images of white light and NIR
fluorescence can be displayed separately and merged. The entire
apparatus is suspended on an articulated arm over the surgical
field, thus permitting noninvasive and nonintrusive imaging. Real-
time video images, refreshed 15 times per second, and zooming
capability allowed precise localization and dissection as needed.
The migration of the lymph tracers from the injection site either
cranially or caudally was imaged in real time. Selected pigs were
imaged 4 hours after injection of QDs and HSA800 to detect new
fluorescence or loss of fluorescence in lymph nodes of the esoph-
agus. SLNs and control nonfluorescing lymph nodes were dis-
sected under NIR-fluorescence image guidance, embedded with
Tissue-Tek OCT compound (Fisher Scientific, Pittsburgh, Pa),
frozen in liquid nitrogen, and sectioned at 6 m. Alternate cuts
were examined by hematoxylin and eosin staining and NIR fluo-
rescence imaging. The NIR fluorescence was visualized through a
modified microscope with custom-designed optics, as described
previously elsewhere.8
Statistical Analysis
Associations between categorical parameters were assessed with
Fisher exact and paired Student t tests.
Results
Direct Injection of QDs into the Esophagus
Intrinsic autofluorescence of the esophagus and surrounding
thoracic tissue was minimal (Figure 1). Direct injection of
QDs into the esophageal wall and QD migration to a single
SLN was visible in real time. A single SLN was identified
within 5 minutes in 100% of pigs (Figure 1). SLN did not
diminish in fluorescence, nor did additional SLNs appear
after 4 hours (data not shown).
Direct and Endoscopic Injection of HSA800 into the
Esophagus
Direct and endoscopic injection of HSA800 produced com-
parative results of bright fluorescence tracer in the wall of
the esophagus against a low background (Figure 2). In 12
pigs receiving HSA800, the mean time of SLN visualization
was 3 minutes, with a range of 30 seconds to 5 minutes
(Figure 3, A ). As with QDs, fluorescence within SLNs did
not diminish, and no additional lymph nodes were found
after 4 hours (Figure 3). One sentinel lymph node was
identified in 5 of the 12 pigs. Two nodes were identified in
7 of the 12 pigs. More specifically, one lymphatic directed
the HSA800 to two different nodes (Figure 3, B ). In 1 case,
the HSA800 entered a node through an efferent lymphatic
c and Cardiovascular Surgery ● Volume 129, Number 4 845
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the node through an afferent lymphatic vessel in a matter of
seconds (Figure 3, C ).
Distribution of SLNs of the Esophagus
There was no predictable distribution of the SLNs in rela-
tion to the injection site (Table 1). Among the 18 pigs
receiving NIR fluorescent tracer injection, 8 had a SLN
cranial to the injection site, and 10 had a SLN caudal to the
Figure 1. QDs migrate from esophagus to specific lym
visualized with color video (left column), NIR fluoresc
column). Lymph nodes shown are positive (arrows) an
same lymph nodes after resection.
TABLE 1. Distribution of the SLNs either cranial or caudal






Proximal esophagus 1 5
Mid esophagus 4 2





Direct injection 6 6
Endoscopic injection 2 4
Total 8 10
Data represent numbers of animals. There was no predictable pattern of
location of the SLNs regardless of location of injection, NIR fluorescent
tracer used, or method of injection (direct or endoscopic).injection site. There was no difference in the distribution of
846 The Journal of Thoracic and Cardiovascular Surgery ● Aprithe SLN when using QDs versus HSA800 (P  .50) or
when using direct injection versus endoscopic injection
(P  .70).
Histologic Results
Hematoxylin and eosin images confirmed that brightly-
fluorescent specimens were lymph nodes. NIR images con-
firmed that both QDs and HSA800 could be detected within
the substructure of the lymph node (Figure 4). HSA800
fluorescence was more robust than QD fluorescence in
histologic samples. As a control, nonfluorescing lymph
nodes were also sectioned and imaged. As expected, these
nodes showed no fluorescence under the NIR-fluorescent
microscope (Figure 4).
Discussion
In esophageal cancer, aggressive lymphadenectomy may
remove tissue at risk of involvement, however, this comes at
the expense of higher morbidity and mortality. An intraop-
erative SLN evaluation could help direct the extent of
lymphadenectomy and thus improve staging and treatment
on a patient-specific basis.9 Although the concept of SLNs
can be applied to esophageal cancer,10 there are several
disadvantages to using technetium Tc 99m and vital blue
dyes. Technetium Tc 99m colloids require radioactive pro-
tocols and storage. The handheld gamma counter not only is
cumbersome but fails to detect more than 50% of radioac-
tive esophageal nodes subsequently identified after resec-
odes of pig. Top row shows in vivo esophagus of pig
(middle column), and color-NIR merge images (right
ative (arrowheads) for QD uptake. Bottom row showsph n
ence
d negtion.5 With technetium Tc 99m, radioactive signal from the
l 2005
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esophageal injection site interferes with detection of SLNs,
also known as “shine-through” effect. Vital blue dyes have
limited application in detection of thoracic lymph nodes
because of the presence of innate lymph node anthracosis.
There is also increasing concern regarding anaphylactic
reactions to vital blue dyes.11
There are several advantages of NIR fluorescence tech-
nology for SLN identification in the esophagus. Both QDs
and HSA800 are powerful lymph tracers that fluoresce
brightly against a low background and distinctly from the
injection site. These NIR-fluorescent lymph tracers do not
leak from tissues, nor do they stain the field of dissection.
Communicating lymph nodes can be seen 5 minutes to 4
Figure 2. In vivo imaging of HSA800 injection into eso
as visualized with color-NIR merge imaging (top row
visualized with color-NIR merge imaging (bottom row
location of HSA800 in esophagus, visualized with color
color-NIR merge images (right column). Top row shows
shows cross section from endoscopic intramural injechours later, thus providing great flexibility of preoperative
The Journal of Thoracior intraoperative administration. With NIR-fluorescent im-
aging, the entire surgical field can be imaged in real-time for
in situ SLNs, thus minimizing sampling error. NIR fluores-
cence imaging can provide magnified images to assist with
precise and complete resection of the SLN without having
to handle another instrument, such as a gamma probe.
NIR-fluorescing tracers withstand histologic processing,
thus providing another degree of certainty in the identifica-
tion of SLNs.
SLN mapping with NIR technology could pose some of
the same challenges as SLN mapping with technetium Tc
99m or vital blue dyes. Tumor within a lymph node could
potentially alter lymphatic flow, deny access of lymph tracer
us of pig. A, HSA800 directly injected into esophagus
HSA800 endoscopically injected into esophagus as
, Cross-section of injection site showing intramural
o (left column), NIR fluorescence (middle column), and




crosto a positive node, and possibly create a false-negative SLN.
c and Cardiovascular Surgery ● Volume 129, Number 4 847
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burden does not increase the false-negative rate.12 Tumor
burden can decrease the success of finding SLNs. Therefore
failure to identify a SLN or suspicious nodes found at the
time of SLN biopsy warrants complete lymphadenectomy.
These studies and practices developed for breast cancer will
have to be explored in esophageal cancer.
NIR-Fluorescent Lymph Tracers
The optimal size of lymph tracers is controversial but
thought to be in the range of 4 to 100 nm.13,14 Because
esophageal cancer appears to metastasize to distant lymph
nodes, suggesting a broad distribution of drainage or skip
metastasis,15 a small, mobile particle such as HSA800 may
be an ideal tracer for SLN mapping. QDs, with a larger
diameter, migrated only to the first draining lymph node. In
contrast, HSA800 could be found in two draining nodes in
Figure 3. HSA800 migrates from esophagus to specific l
visualized with color video (left), NIR fluorescence (m
HSA800-positive lymph node. B, Three examples of two
single injection site into pig esophagus (Inj). C, Exampl
node (arrow) and afferent lymphatic (A) leaving same
fluorescence images have identical exposure times an7 of 12 pigs. In 1 case, HSA800 identified a lymph node and
848 The Journal of Thoracic and Cardiovascular Surgery ● Aprialso partially traveled out to identify a second lymph node.
Because HSA800 is smaller than QDs, it may have access to
smaller lymphatics that QDs cannot traverse. The clinical
significance of a second SLN in the esophagus will have to
be determined with future studies. However, the presence of
multiple communicating nodes and even multiple lymphatic
patterns does not preclude the application of accurate SLN
identification in the esophagus. Multiple SLNs are phenom-
enon accepted in SLN mapping of breast and melanoma.16
In fact, the identification of multiple SLNs improved the
false-negative rate to 4.3% from 14.3% when only one SLN
was identified.17 The ability of HSA800 to identify multiple
nodes may make it a better lymph tracer to limit false-
negative results; however, specific studies directed at this
question will have to be performed.
A potential limitation of QDs is their unknown toxicity.
The individual metals comprising the inorganic core and
nodes of pig. A, Top row shows in vivo pig esophagus
e), and color-NIR merge images (right). Arrows mark
800-positive lymph nodes (arrows) being imaged from
fferent lymphatic (E) leading to HSA800-positive lymph





lympshell have known toxic effects, especially at concentrations
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metals when complexed as salts in the core of a QD is
unknown. In our studies, there were no signs of acute
toxicity, namely changes in heart rate, rhythm, blood pres-
sure, or oxygen saturation. HSA800 has greater potential for
immediate clinical application because it is purely organic
and is the product of nontoxic components. However, stud-
ies directed at establishing the toxicity, if any, of these
tracers must still be performed before applying the technol-
ogy to human patients.
Last, our data corroborate earlier studies showing an
unpredictable drainage pattern of the esophagus.18 Injec-
tions of the lymph tracers, whether direct or endoscopic,
were performed by the same surgeon with identical tech-
nique. Yet, regardless of tracer size, mode of injection, or
location of injection, there was no consistent pattern of
Figure 4. Histologic photomicrographs of NIR-fluoresce
lymph node of pig with hematoxylin and eosin (H&E)
node imaged for NIR fluorescence (right). Second row
HSA800-positive lymph node of pig. Bottom row shows
and negative NIR fluorescence images have identical
100.)drainage from injection sites. These findings emphasize the
The Journal of Thoracineed for a reliable, sensitive, patient-specific method for
identifying SLNs of the esophagus. NIR-fluorescence im-
aging is not only a promising method for identifying
SLNs but also a powerful instrument for image-guided
dissection.
Advancing this technology to SLN biopsy in human
beings could have clinical impact on both staging and
treatment in esophageal cancer. Selective removal of the
SLNs could provide staging information without the mor-
bidity and mortality of routine extensive lymphadenectomy.
If the SLN proved positive, aggressive treatment options
such as extended lymphadenectomy or more aggressive
adjuvant therapy could be appropriately offered. In conclu-
sion, our studies show the feasibility of patient-specific
identification of SLNs of the esophagus with NIR fluores-
cence technology. However, further studies are needed to
sitive and negative tissue. Top row shows QD-positive
ing (left) and consecutive unstained section of same
ws QD-negative lymph node of pig. Third row shows
00-negative lymph node of pig. Corresponding positive




expoapply this technique in humans.
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